Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update

Apollomics, Inc. (NASDAQ:APLMW) saw a large decline in short interest in August. As of August 15th, there was short interest totalling 4,200 shares, a decline of 78.2% from the July 31st total of 19,300 shares. Based on an average daily trading volume, of 21,000 shares, the short-interest ratio is presently 0.2 days.

Apollomics Price Performance

NASDAQ:APLMW remained flat at $0.01 during mid-day trading on Thursday. Apollomics has a 1 year low of $0.01 and a 1 year high of $0.10. The company has a 50 day simple moving average of $0.01 and a 200-day simple moving average of $0.02.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.